Connection
Enrique Alvarez to Administration, Intravenous
This is a "connection" page, showing publications Enrique Alvarez has written about Administration, Intravenous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.219 |
|
|
|
-
Hua LH, Brown B, Camacho E, Chinea AR, Greenberg BM, Henry RG, Houtsma E, Moreo N, Alvarez E. Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study. J Neurol. 2025 Oct 24; 272(11):725.
Score: 0.219